Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision history updated to include v3.3.4 and remove v3.3.3 for the study NCT04293276.
    Difference
    0.1%
    Check dated 2026-01-14T02:34:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page history now shows a new revision (v3.3.3); the HHS Vulnerability Disclosure link and the older revision (v3.3.2) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T20:41:32.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The Record History now shows a new revision: v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:40.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the generic government funding/operating status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:11:44.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Version history shows updates to Recruitment Status and Study Status across several releases, reflecting changes in the trial’s enrollment and activity. The most recent version (2023-05-03) includes changes to Recruitment Status and Study Status.
    Difference
    0.1%
    Check dated 2025-11-03T21:07:52.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    13%
    Check dated 2025-10-06T05:32:53.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.